Granules India receives USFDA approval for Acetaminophen 650 mg Tablets
Capital Market Granules India announced that the US FDA has
approved its Abbreviated New Drug Application (ANDA) for Acetaminophen 650 mg Tablets,
Extended Release, bioequivalent to the reference listed drug product (RiD), Tylenol 650mg
tablets, Extended Release. The ANDA was filed by Granules Pharmaceuticals Inc, a wholly
owned subsidiary of Granules lndia.
Acetaminophen 650 mg extended release tablets are. used primarily for temporary pain
management including arthritis relief
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
